Application of Nanobubbles in Floating Kinetics Models for Efficient Oil Removal from Produced Water von Daud, M F C, Khamidun, M H, Mohamed, R M S R, Ali, U F M, Razi, M A M

Volltext

A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments von Barry, Kevin C., Hsu, Joy, Broz, Miranda L., Cueto, Francisco J., Binnewies, Mikhail, Combes, Alexis J., Nelson, Amanda E., Loo, Kimberly, Kumar, Raj, Rosenblum, Michael D., Alvarado, Michael D., Wolf, Denise M., Bogunovic, Dusan, Bhardwaj, Nina, Daud, Adil I., Ha, Patrick K., Ryan, William R., Pollack, Joshua L., Samad, Bushra, Asthana, Saurabh, Chan, Vincent, Krummel, Matthew F.

Volltext

Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity von Binnewies, Mikhail, Mujal, Adriana M., Pollack, Joshua L., Combes, Alexis J., Hardison, Emily A., Barry, Kevin C., Tsui, Jessica, Ruhland, Megan K., Kersten, Kelly, Abushawish, Marwan A., Spasic, Marko, Giurintano, Jonathan P., Chan, Vincent, Daud, Adil I., Ha, Patrick, Ye, Chun J., Roberts, Edward W., Krummel, Matthew F.

Volltext

Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma von Daud, Adil I, Wolchok, Jedd D, Robert, Caroline, Hwu, Wen-Jen, Weber, Jeffrey S, Ribas, Antoni, Hodi, F Stephen, Joshua, Anthony M, Kefford, Richard, Hersey, Peter, Joseph, Richard, Gangadhar, Tara C, Dronca, Roxana, Patnaik, Amita, Zarour, Hassane, Roach, Charlotte, Toland, Grant, Lunceford, Jared K, Li, Xiaoyun Nicole, Emancipator, Kenneth, Dolled-Filhart, Marisa, Kang, S Peter, Ebbinghaus, Scot, Hamid, Omid

Volltext

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 von Hamid, O., Robert, C., Daud, A., Hodi, F.S., Hwu, W.J., Kefford, R., Wolchok, J.D., Hersey, P., Joseph, R., Weber, J.S., Dronca, R., Mitchell, T.C., Patnaik, A., Zarour, H.M., Joshua, A.M., Zhao, Q., Jensen, E., Ahsan, S., Ibrahim, N., Ribas, A.

Volltext

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial von Robert, Caroline, Prof, Ribas, Antoni, Prof, Wolchok, Jedd D, Prof, Hodi, F Stephen, MD, Hamid, Omid, MD, Kefford, Richard, Prof, Weber, Jeffrey S, Prof, Joshua, Anthony M, PhD, Hwu, Wen-Jen, Prof, Gangadhar, Tara C, MD, Patnaik, Amita, MD, Dronca, Roxana, MD, Zarour, Hassane, Prof, Joseph, Richard W, MD, Boasberg, Peter, MD, Chmielowski, Bartosz, MD, Mateus, Christine, MD, Postow, Michael A, MD, Gergich, Kevin, MA, Elassaiss-Schaap, Jeroen, PhD, Li, Xiaoyun Nicole, PhD, Iannone, Robert, MD, Ebbinghaus, Scot W, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma von Robert, Caroline, Hwu, Wen-Jen, Hamid, Omid, Ribas, Antoni, Weber, Jeffrey S., Daud, Adil I., Hodi, F. Stephen, Wolchok, Jedd D., Mitchell, Tara C., Hersey, Peter, Dronca, Roxana, Joseph, Richard W., Boutros, Celine, Min, Le, Long, Georgina V., Schachter, Jacob, Puzanov, Igor, Dummer, Reinhard, Lin, Jianxin, Ibrahim, Nageatte, Diede, Scott J., Carlino, Matteo S., Joshua, Anthony M.

Volltext

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial von Ribas, Antoni, Prof, Puzanov, Igor, MD, Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Hamid, Omid, MD, Robert, Caroline, Prof, Hodi, F Stephen, MD, Schachter, Jacob, Prof, Pavlick, Anna C, MD, Lewis, Karl D, MD, Cranmer, Lee D, MD, Blank, Christian U, MD, O'Day, Steven J, MD, Ascierto, Paolo A, Prof, Salama, April K S, MD, Margolin, Kim A, Prof, Loquai, Carmen, MD, Eigentler, Thomas K, MD, Gangadhar, Tara C, MD, Carlino, Matteo S, MBBS, Agarwala, Sanjiv S, Prof, Moschos, Stergios J, MD, Sosman, Jeffrey A, Prof, Goldinger, Simone M, MD, Shapira-Frommer, Ronnie, MD, Gonzalez, Rene, Prof, Kirkwood, John M, Prof, Wolchok, Jedd D, Prof, Eggermont, Alexander, Prof, Li, Xiaoyun Nicole, PhD, Zhou, Wei, PhD, Zernhelt, Adriane M, BS, Lis, Joy, BSN, Ebbinghaus, Scot, MD, Kang, S Peter, MD, Daud, Adil, Prof

Volltext

Effects of dietary mono- and multiprobiotic strains on growth performance, gut bacteria and body composition of Javanese carp (Puntius gonionotus, Bleeker 1850) von Allameh, S.K., Yusoff, F.M., Ringø, E., Daud, H.M., Saad, C.R., Ideris, A.

Volltext

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma von Hamid, Omid, Robert, Caroline, Daud, Adil, Hodi, F. Stephen, Hwu, Wen-Jen, Kefford, Richard, Wolchok, Jedd D, Hersey, Peter, Joseph, Richard W, Weber, Jeffrey S, Dronca, Roxana, Gangadhar, Tara C, Patnaik, Amita, Zarour, Hassane, Joshua, Anthony M, Gergich, Kevin, Elassaiss-Schaap, Jeroen, Algazi, Alain, Mateus, Christine, Boasberg, Peter, Tumeh, Paul C, Chmielowski, Bartosz, Ebbinghaus, Scot W, Li, Xiaoyun Nicole, Kang, S. Peter, Ribas, Antoni

Volltext

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma von Weber, Jeffrey, Mandala, Mario, Del Vecchio, Michele, Gogas, Helen J, Arance, Ana M, Cowey, C. Lance, Dalle, Stéphane, Schenker, Michael, Chiarion-Sileni, Vanna, Marquez-Rodas, Ivan, Grob, Jean-Jacques, Butler, Marcus O, Middleton, Mark R, Maio, Michele, Atkinson, Victoria, Queirolo, Paola, Gonzalez, Rene, Kudchadkar, Ragini R, Smylie, Michael, Meyer, Nicolas, Mortier, Laurent, Atkins, Michael B, Long, Georgina V, Bhatia, Shailender, Lebbé, Celeste, Rutkowski, Piotr, Yokota, Kenji, Yamazaki, Naoya, Kim, Tae M, de Pril, Veerle, Sabater, Javier, Qureshi, Anila, Larkin, James, Ascierto, Paolo A

Volltext

Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial von Guo, J., Carvajal, R.D., Dummer, R., Hauschild, A., Daud, A., Bastian, B.C., Markovic, S.N., Queirolo, P., Arance, A., Berking, C., Camargo, V., Herchenhorn, D., Petrella, T.M., Schadendorf, D., Sharfman, W., Testori, A., Novick, S., Hertle, S., Nourry, C., Chen, Q., Hodi, F.S.

Volltext

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial von Algazi, Alain P., Othus, Megan, Daud, Adil I., Lo, Roger S., Mehnert, Janice M., Truong, Thach-Giao, Conry, Robert, Kendra, Kari, Doolittle, Gary C., Clark, Joseph I., Messino, Michael J., Moore, Dennis F., Lao, Christopher, Faller, Bryan A., Govindarajan, Rangaswamy, Harker-Murray, Amy, Dreisbach, Luke, Moon, James, Grossmann, Kenneth F., Ribas, Antoni

Volltext

International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module von Zand, Farid, El-Kholy, Amani, Rai, Vineya, Anguseva, Tanja, Ikram, Aamer, Sandoval-Castillo, Harrison Ronald, Bourlot, I., García, M., Arregui, N.V., Humood, M.Z., Swar, S., Sugette-de-Aguiar, T., Moreira, T., Rodrigues-Amarilo, N., Azevedo-Ferreira-Lima, D., Servolo-Medeiros, E.A., Cañas-Giraldo, L.M., González-Rubio, P.A., Vargas-Garcia, A.R., Roncancio, E.G., Chapeta-Parada, E.G., Martinez, A., Salgado-Yepez, E., Valencia, F., Caballero-Narvaez, H., Ahmed, S.A., El-Fattah, M.A., Abdel-Aziz, D.M., Helal, A.M., Kamal-Elden, N.M., Chabukswar, S., Anju, M., Nair, P.K., Kharbanda, M., Divatia, J.V., Sanyal, S., Valsa, T., Mani, A.K., Tamboli, A.S., Mishra, S., Sharma, C.B., Kaur, A., Pillai, S., ALazhary, M., Alabdely, H.M., Ahmed, H., Rajavel, R.D., Turkistani, A.A., Abraham, S., Esam, B., Aldossary, A.H., Al-Suliman, S., HaqlreMia, M.E., Alradady, M., Raees, M., Abdulatif, S.M., Ali-Karrar, M.A., Jaha, R.N., Kurian, A., Foda-Salama, M., Ahmadieh, R., Mahfouz, T., Kondratas, T., Petrovska, M., Altuzar-Figueroa, M.A., Aragon, D.M.L., Sanchez-Rivas, M., Monroy-Colin, V.A., Guido-Ramirez, O., Battsetseg, T., Tsolmon, B., Saranbaatar, A., Zeggwagh, A.A., Nizamuddin, S., Sultan, F., Zahra, F.T., Daud, N., Ali, S.R., Castaño, E.G., Labro, E., Cesar, J.L., Domanska, M., Kolat-Brodecka, P., Smiechowicz, K., Kojovic, J., Abdo-Ali, M.M., Cabadak, H., Sebnem, F.E., Ersoz, G., Altindis, M., Oncul, A., Ceylan, G., Cengiz, M., Yalcin, A.N., Kocagoz, A.S., Perez, F., Sanchez, E., Nguyet, L.T.T., Hang, T.T.T., Anh, D.P.P.

Volltext

Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma von Robert, Caroline, Ribas, Antoni, Hamid, Omid, Daud, Adil, Wolchok, Jedd D, Joshua, Anthony M, Hwu, Wen-Jen, Weber, Jeffrey S, Gangadhar, Tara C, Joseph, Richard W, Dronca, Roxana, Patnaik, Amita, Zarour, Hassane, Kefford, Richard, Hersey, Peter, Zhang, Jin, Anderson, James, Diede, Scott J, Ebbinghaus, Scot, Hodi, F Stephen

Volltext

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab von Hodi, F Stephen, Hwu, Wen-Jen, Kefford, Richard, Weber, Jeffrey S, Daud, Adil, Hamid, Omid, Patnaik, Amita, Ribas, Antoni, Robert, Caroline, Gangadhar, Tara C, Joshua, Anthony M, Hersey, Peter, Dronca, Roxana, Joseph, Richard, Hille, Darcy, Xue, Dahai, Li, Xiaoyun Nicole, Kang, S Peter, Ebbinghaus, Scot, Perrone, Andrea, Wolchok, Jedd D

Volltext

Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma von Levine, Lauren S., Mahuron, Kelly M., Tsai, Katy K., Wu, Clinton, Mattis, Daiva M., Pauli, Mariela L., Oglesby, Arielle, Lee, James C., Spitzer, Matthew H., Krummel, Matthew F., Algazi, Alain P., Rosenblum, Michael D., Alvarado, Michael, Daud, Adil I.

Volltext

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab von Joseph, Richard W, Elassaiss-Schaap, Jeroen, Kefford, Richard, Hwu, Wen-Jen, Wolchok, Jedd D, Joshua, Anthony M, Ribas, Antoni, Hodi, F Stephen, Hamid, Omid, Robert, Caroline, Daud, Adil, Dronca, Roxana, Hersey, Peter, Weber, Jeffrey S, Patnaik, Amita, de Alwis, Dinesh P, Perrone, Andrea, Zhang, Jin, Kang, S Peter, Ebbinghaus, Scot, Anderson, Keaven M, Gangadhar, Tara C

Volltext

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma von Ribas, Antoni, Hamid, Omid, Daud, Adil, Hodi, F. Stephen, Wolchok, Jedd D, Kefford, Richard, Joshua, Anthony M, Patnaik, Amita, Hwu, Wen-Jen, Weber, Jeffrey S, Gangadhar, Tara C, Hersey, Peter, Dronca, Roxana, Joseph, Richard W, Zarour, Hassane, Chmielowski, Bartosz, Lawrence, Donald P, Algazi, Alain, Rizvi, Naiyer A, Hoffner, Brianna, Mateus, Christine, Gergich, Kevin, Lindia, Jill A, Giannotti, Maxine, Li, Xiaoyun Nicole, Ebbinghaus, Scot, Kang, S. Peter, Robert, Caroline

Volltext

Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium von Amaria, Rodabe N, Menzies, Alexander M, Burton, Elizabeth M, Scolyer, Richard A, Tetzlaff, Michael T, Antdbacka, Robert, Ariyan, Charlotte, Bassett, Roland, Carter, Brett, Daud, Adil, Faries, Mark, Fecher, Leslie A, Flaherty, Keith T, Gershenwald, Jeffrey E, Hamid, Omid, Hong, Angela, Kirkwood, John M, Lo, Serigne, Margolin, Kim, Messina, Jane, Postow, Michael A, Rizos, Helen, Ross, Merrick I, Rozeman, Elisa A, Saw, Robyn P M, Sondak, Vernon, Sullivan, Ryan J, Taube, Janis M, Thompson, John F, van de Wiel, Bart A, Eggermont, Alexander M, Davies, Michael A, Andrews, Miles C, Berry, Donald A, Block, Matthew S, Boland, Genevieve M, Bollin, Kathryn B, Carlino, Matteo S, Carvajal, Richard D, Cohen, Jonathan, Davar, Diwakar, Delman, Keith A, Dummer, Reinhard, Farwell, Michael D, Fisher, David E, Fusi, Alberto, Glitza, Isabella C, de Gruijl, Tanja D, Gyorki, David E, Hauschild, Axel, Hieken, Tina J, Larkin, James, Lawson, David H, Lebbe, Celeste, Lee, Jeffrey E, Lowe, Michael C, Luke, Jason J, McArthur, Grant A, McDermott, David F, McQuade, Jennifer L, Mitchell, Tara C, Petrella, Teresa M, Prieto, Peter A, Puzanov, Igor, Robert, Caroline, Salama, April K, Sandhu, Shaneen, Schadendorf, Dirk, Shoushtari, Alexander N, Sosman, Jeffrey A, Swetter, Susan M, Tanabe, Ken K, Turajlic, Samra, Tyler, Douglas S, Woodman, Scott E, Wright, Frances C, Zager, Jonathan S, Ascierto, Paolo A, Spillane, Andrew J, van Akkooi, Alexander C J, Wargo, Jennifer A, Blank, Christian U, Tawbi, Hussein A, Long, Georgina V

Volltext